Abstract CT191: Interim results from CLASSICAL-Lung, phase 1b/2 study of pepinemab (VX15/2503) in combination with avelumab in advanced NSCLC
Year: 2020
Type: conference-abstract
Source: Cancer Research
Authors: Jonathan W. Goldman, Terrence L. Fisher, Elizabeth Evans, John E. Leonard, Desa Rae Pastore, Crystal Mallow, Ernest Smith, Andreas Schröeder, Kevin Chin, Michael Shafique, Thaddeus Beck, Megan A. Baumgart, Ramaswamy Govindan, Nashat Gabrail, Rachel E. Sanborn, Alexander I. Spira, Nagashree Seetharamu, Yanyan Lou, Aaron S. Mansfield, Maurice Zauderer
Institutions: University of California, Los Angeles, Vaccinex (United States), Merck KGaA, Darmstadt (Germany), Moffitt Cancer Center, Highlands Oncology Group, University of Rochester, Washington University in St. Louis, Gabrail Cancer Center, Providence Portland Medical Center, Virginia Cancer Specialists, Northwell Health, Mayo Clinic in Florida, Mayo Clinic
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3083467148